1. Colombia Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Blueberries Medical Corp.

Blueberries Medical Corp.

BBM.CN
Blueberries Medical Corp.CA flagCanadian Securities Exchange
0.01
CAD
- -
- -
4.95MMarket Cap
Blueberries Medical Corp.
BBM.CN
(Canadian Securities Exchange)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.2
-0.04
-0.06
-0.19
-0.01
-0.1
-0.04
-0.03
-0.01
-0.01
- -
- -
- -
Basic EPS, GAAP
- -
-0.07
-0.04
-0.06
-0.05
- -
-0.08
-0.03
-0.01
-0.01
-0.01
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.21
-0.26
-0.32
-0.51
-0.45
0.02
-0.02
-0.03
-0.03
-0.02
-0.01
-0.01
-0.01
Book Value per Share
- -
0.15
0.11
0.05
-0.14
-0.03
0.06
0.02
0.01
0.01
0.01
- -
- -
- -
Tangible Book Value per Share
- -
2
2
2
2
3
109
124
149
169
219
399
473
495
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
-6,251.54
-1,289.55
-696.79
-477.44
-193.7
-441.57
-257.68
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
-11
-5
-5
-1
-2
-1
-2
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
-7,487.51
-3,709.64
-623.44
-567.3
-243.64
-533.44
-352.85
Profit Margin (%)
- -
- -
- -
- -
- -
- -
2
-2
- -
- -
1
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
8
4
1
1
2
1
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
495
495
495
Market Capitalization
7
5
7

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,231.85%
-29.37%
-61.53%
Free Cash Flow
7,085%
-10.98%
56%
Net Income, GAAP
6,969.76%
-8.12%
45.04%
Sales/Revenue/Turnover
- -
46.44%
-33.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Eve & Co Incorporated (EEVVF)
Xuanzhubio-b (2575.HK)
CENTR Brands Corp. (CNTRF)
Alterola Biotech, Inc. (ABTI)
Faes Farma, S.A. (FAE.MC)
Bhang Inc. (BHNG.CN)
Business
Blueberries Medical Corp. (CSE: BBM), a Colombia-based licensed producer of medicinal cannabis and plant-derived bioactives founded in 2013 and headquartered in Bogotá, engages in the cultivation, extraction, manufacturing, and distribution of pharmaceutical-grade cannabis derivatives including CBD isolates, THC oils and distillates, premium medical flowers, water-soluble specialties, food-grade extracts, and magistral formulas; alongside functional supplements, wellness products, botanical ingredients, and natural health solutions targeting pharmaceutical, nutraceutical, and consumer markets in Colombia, Peru, and international regions. As a key operating subsidiary within Terraflos Inc., the company leverages advanced extraction technologies and GACP-certified third-party cultivation partnerships to supply standardized active pharmaceutical ingredients for functional foods, supplements, and skincare, while holding comprehensive Colombian licenses for psychoactive and non-psychoactive cannabis production, domestic commercialization, and export through its wholly owned subsidiary Blueberries SAS. Recent developments include regulatory approval in February 2025 for commercial pharmaceutical-grade THC supply, closure of a C$1.06 million CEO-led non-brokered private placement in March 2025 to fund operational expansion and working capital, advancement of technical validations with pharmaceutical clients and preparations to resume exports to Peru, strategic diversification into food tech and biotechnology-based products beyond core cannabis operations, and a shift to an asset-light model emphasizing recurring high-margin derivative sales.